Free shipping on all orders over $ 500

BMS-708163

Cat. No. M1947

All AbMole products are for research use only, cannot be used for human consumption.

BMS-708163 Structure
Synonym:

Avagacestat

Size Price Availability Quantity
1mg USD 70 In stock
5mg USD 150 In stock
10mg USD 240 In stock
25mg USD 450 In stock
50mg USD 660 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

BMS-708163 (Avagacestat) is a potent, selective γ-secretase inhibitor of Aβ40 and Aβ42 with IC50 of 0.3 nM and 0.27 nM, respectively. BMS-708163 binds directly to the presenilin-1 N-terminal fragment and that binding can be challenged by other pan-GSIs, but not by γ-secretase modulators. BMS-708163 blocks the binding of four different active site-directed GSI photoaffinity probes. Administration of a single dose of 200 or 400 mg of BMS-708163 resulted in a marked decrease in CSF Aβ(1-38), Aβ(1-40) and Aβ(1-42) concentrations vs placebo; with smaller decreases observed in the 50 mg dose group. BMS-708163 (Avagacestat) was quickly absorbed into the systemic circulation, with a mean time to reach maximum plasma concentration (t(max)) of approximately 1-2 h, and a CSF t(max) of approximately 3 h. BMS-708163 is 190-fold more selective for APP than Notch, having an IC50 of 58 nM for Notch.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models Harlan Sprague Dawley rat or ATM-405-142K9 naive II dog
Formulation 99% PEG-400, 1% Tween-80 (rat),or 94% labrafil-1944, 5% ethanol, 1% Tween-80 (dog)
Dosages 10 mg/kg (rat) or 2.5 mg/kg (dog)
Administration oral gavage
Chemical Information
Molecular Weight 520.88
Formula C20H17ClF4N4O4S
CAS Number 1146699-66-2
Solubility (25°C) DMSO 100 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Gillman KW, et al. ACS Med Chem Lett. Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor.

[2] Tong G, et al. Clin Drug Investig. Effects of Single Doses of Avagacestat (BMS-708163) on Cerebrospinal Fluid Aβ Levels in Healthy Young Men.

[3] Crump CJ, et al. Biochemistry. BMS-708,163 targets presenilin and lacks notch-sparing activity.

Related Gamma-secretase/Beta-secretase Products
DAPT

DAPT (GSI-IX) is a γ-secretase inhibitor with IC50 values of 115 and 200 nM for total Aβ and Aβ42 respectively. DAPT inhibits the activation of Notch 1 signaling.

RO4929097

RO4929097 is a potent and selective inhibitor of γ-secretase and as a result is able to inhibit Notch pathway signaling.

MK-0752

MK-0752 is a potent, oral inhibitor of γ-secretase with IC50 of 5 nM in human SH-SY5Y cells.

LY-411575

LY-411575 is potent and selective small molecule γ-secretase inhibitor with IC50 of 0.1 nM for APP23 and APP51/16 primary neurons.

LY2811376

LY2811376 is an orally available, non-peptidic β-secretase inhibitor with IC50 of 239 nM-249 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: BMS-708163, Avagacestat supplier, Gamma-secretase/Beta-secretase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.